SCIT Versus SLIT: Which One Do You Recommend, Doc?

Mohamad R. Chaaban, Ahmed Mansi, Julia W. Tripple, Sarah K. Wise

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Allergic rhinitis is a prevalent condition that has a significant impact on the quality of life of many patients. When initial therapy fails to control the symptoms, allergen immunotherapy (AIT) has been suggested as an option by the Joint Task Force on Practice Parameters. The 2 main forms of AIT are via subcutaneous and sublingual routes, called subcutaneous immunotherapy and sublingual immunotherapy, respectively. There is debate about which is the better option for patients with each method offering its own pros and cons. We present 2 patients with allergic rhinitisAR that were deemed good candidates for AIT and explore current evidence for both subcutaneous immunotherapy and sublingual immunotherapy. The advantages and disadvantages of each method are discussed with the goal of providing a framework for the physician when deciding on AIT for their patients. In addition, we explore the use of AIT in patients with asthma and atopic dermatitis as potential patient populations that may benefit from the treatment. We use the discussion to provide recommendations regarding which method of AIT is best suited for both our patients.

Original languageEnglish (US)
Pages (from-to)442-447
Number of pages6
JournalAmerican Journal of the Medical Sciences
Issue number5
StatePublished - May 2019

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'SCIT Versus SLIT: Which One Do You Recommend, Doc?'. Together they form a unique fingerprint.

Cite this